SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000886163-22-000039
Filing Date
2022-04-22
Accepted
2022-04-22 16:12:42
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A ligand-2022proxysupplement.htm DEFA14A 9814
2 image.jpg GRAPHIC 238996
3 image1.jpg GRAPHIC 244721
4 image_0.jpg GRAPHIC 12141
  Complete submission text file 0000886163-22-000039.txt   688139
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33093 | Film No.: 22845641
SIC: 2834 Pharmaceutical Preparations